We’re celebrating National Democracy Week! Find out more

Cannabis: Medical Treatments

Department of Health and Social Care written question – answered on 9th July 2018.

Alert me about debates like this

Photo of Caroline Lucas Caroline Lucas Co-Leader of the Green Party

To ask the Secretary of State for Health and Social Care, what discussions his Department has had with representatives of the medicinal cannabis industry on the medicinal and therapeutic benefits of (a) cannabis and (b) cannabis-based medicinal products.

Photo of Steve Brine Steve Brine The Parliamentary Under-Secretary for Health and Social Care

On 13 June 2018 the Parliamentary Under Secretary of State for Health (Lord O’Shaughnessy) and officials had an introductory meeting with GW Pharmaceuticals, which develops licensed medicines containing ingredients derived from cannabis, during which the benefits of that company’s medicines were discussed.

The Medicines and Healthcare products Regulatory Agency is responsible for the regulation of medicines in the United Kingdom and has provided advice and guidance, on request, to companies developing cannabis-based medicinal products, to support specific medical indications in relation to potential future marketing authorisation applications for new medicines.

Does this answer the above question?

Yes1 person thinks so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.